Results 31 to 40 of about 136,700 (260)

Stratification of Systemic Lupus Erythematosus Patients Using Gene Expression Data to Reveal Expression of Distinct Immune Pathways [PDF]

open access: yes, 2020
Systemic lupus erythematosus (SLE) is the tenth leading cause of death in females 15-24 years old in the US. The diversity of symptoms and immune pathways expressed in SLE patients causes difficulties in treating SLE as well as in new clinical trials.
arxiv   +1 more source

Current concepts of photosensitivity in cutaneous lupus erythematosus

open access: yesFrontiers in Medicine, 2022
Cutaneous lupus erythematosus (CLE) represents a complex autoimmune disease with a broad phenotypic spectrum ranging from acute to chronic destructive cutaneous lesions. Patients with CLE exhibit high photosensitivity and ultraviolet (UV) irradiation can
Benjamin Klein, Manfred Kunz
doaj   +1 more source

Break down the barriers of auto‐inflammation: How to deal with a monogenic auto‐inflammatory disease and immuno‐haematological features in 2022?

open access: yesImmunology, Volume 168, Issue 1, Page 1-17, January 2023., 2023
In the past few years, the spectrum of monogenic systemic auto‐inflammatory diseases has widely expanded beyond the typical recurrent fever. Immuno‐haematological features, as cytopenias, hypogammaglobulinemia, hypereosinophilia, lymphoproliferation and immunodeficiency, have been described in association of several MSAID.
Hélène Vergneault   +2 more
wiley   +1 more source

Achados capilaroscópicos no lúpus eritematoso Capillaroscopy findings in lupus erythematosus

open access: yesAnais Brasileiros de Dermatologia, 2006
FUNDAMENTOS: A capilaroscopia é método não invasivo e reprodutível capaz de analisar diretamente os capilares na região periungueal, auxiliando no diagnóstico diferencial das doenças do tecido conectivo.
Anamaria da Silva Facina   +4 more
doaj   +1 more source

Chronic cutaneous lupus erythematosus in a blaschkoid pattern over face

open access: yesIndian Journal of Dermatology, 2018
Linear lesions following the lines of Blaschko of chronic cutaneous lupus erythematosus is a highly unusual variant of cutaneous lupus, particularly in adult.
Manju Meena   +3 more
doaj   +1 more source

Natural language processing to identify lupus nephritis phenotype in electronic health records [PDF]

open access: yesarXiv, 2021
Systemic lupus erythematosus (SLE) is a rare autoimmune disorder characterized by an unpredictable course of flares and remission with diverse manifestations. Lupus nephritis, one of the major disease manifestations of SLE for organ damage and mortality, is a key component of lupus classification criteria.
arxiv  

Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis

open access: yesFrontiers in Immunology, 2020
Cutaneous Lupus Erythematosus (CLE) is a clinically diverse group of autoimmune skin diseases with shared histological features of interface dermatitis and autoantibodies deposited at the dermal–epidermal junction.
Colton J. Garelli   +5 more
semanticscholar   +1 more source

Classification of histopathology images using ConvNets to detect Lupus Nephritis [PDF]

open access: yesarXiv, 2021
Systemic lupus erythematosus (SLE) is an autoimmune disease in which the immune system of the patient starts attacking healthy tissues of the body. Lupus Nephritis (LN) refers to the inflammation of kidney tissues resulting in renal failure due to these attacks.
arxiv  

SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS WITH PSEUDO-PORPHYRIA AND VITILIGO

open access: yesJournal of Nepal Medical Association, 2003
Sub acute Cutaneous Lupus Erythematosus (SCLE) is a distinct subset of Lupus Erythematosus. It can present as non scarring psoriasiform or annular polycyclic lesions.
H Sripathi, M Dahal, A Basu
doaj   +1 more source

Manifestation of subacute cutaneous lupus erythematosus during treatment with anti-PD-1 antibody cemiplimab – a case report

open access: yesFrontiers in Immunology, 2023
IntroductionThe anti-programmed cell death protein 1 (PD-1) antibody cemiplimab has shown promising results in the treatment of unresectable or metastatic squamous cell carcinoma, however, frequently leads to immune-related adverse events limiting ...
Simon Fietz   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy